B G Druss1, R M Rohrbaugh, R A Rosenheck. 1. Northeast Program Evaluation Center, VA Healthcare System, and the Department of Psychiatry and Public Health, Yale University, West Haven, Conn., USA. benjamin.druss@yale.edu
Abstract
OBJECTIVE: The authors assessed the association between depressive symptoms and health costs for a national Veterans Administration (VA) sample. METHOD: The Rand Depression Index was administered to 1,316 medical or surgical inpatients over the age of 60 at nine VA hospitals. Scores were merged with utilization, demographic, and hospital data from national VA inpatient and outpatient files. RESULTS: Medical costs for respondents with the highest quartile of symptoms were approximately $3,200-or 50%-greater than medical costs for those in the least symptomatic quartile. Depressive symptoms were not associated with any statistically significant mental health expenditures. CONCLUSIONS: The study extends previous reports of the high medical costs associated with depressive disorders to an older, public sector population. The mechanisms underlying increased medical costs associated with depressive symptoms, while the subject of much speculation in the literature, still remain largely unknown.
OBJECTIVE: The authors assessed the association between depressive symptoms and health costs for a national Veterans Administration (VA) sample. METHOD: The Rand Depression Index was administered to 1,316 medical or surgical inpatients over the age of 60 at nine VA hospitals. Scores were merged with utilization, demographic, and hospital data from national VA inpatient and outpatient files. RESULTS: Medical costs for respondents with the highest quartile of symptoms were approximately $3,200-or 50%-greater than medical costs for those in the least symptomatic quartile. Depressive symptoms were not associated with any statistically significant mental health expenditures. CONCLUSIONS: The study extends previous reports of the high medical costs associated with depressive disorders to an older, public sector population. The mechanisms underlying increased medical costs associated with depressive symptoms, while the subject of much speculation in the literature, still remain largely unknown.
Authors: Anthony P King; James L Abelson; Bardia Gholami; Gilbert R Upchurch; Peter Henke; Linda Graham; Israel Liberzon Journal: Psychosom Med Date: 2015 Nov-Dec Impact factor: 4.312
Authors: Roger G Kathol; Donna McAlpine; Yasuhiro Kishi; Robert Spies; William Meller; Terence Bernhardt; Steven Eisenberg; Keith Folkert; William Gold Journal: J Gen Intern Med Date: 2005-02 Impact factor: 5.128
Authors: Christian J Nelson; Christina Cho; Alexandra R Berk; Jimmie Holland; Andrew J Roth Journal: J Clin Oncol Date: 2009-12-07 Impact factor: 44.544
Authors: Julie M Donohue; Yuting Zhang; Men Aiju; Subashan Perera; Judith R Lave; Joseph T Hanlon; Charles F Reynolds Journal: Am J Geriatr Psychiatry Date: 2011-12 Impact factor: 4.105
Authors: Rebecca M Saracino; Mark I Weinberger; Andrew J Roth; Arti Hurria; Christian J Nelson Journal: Psychooncology Date: 2016-05-16 Impact factor: 3.894
Authors: Patrick J Raue; Herbert C Schulberg; Roberto Lewis-Fernandez; Carla Boutin-Foster; Amy S Hoffman; Martha L Bruce Journal: Int J Geriatr Psychiatry Date: 2010-11 Impact factor: 3.485
Authors: Whitney P Witt; Robert Kahn; Lisa Fortuna; Jonathan Winickoff; Karen Kuhlthau; Paul A Pirraglia; Timothy Ferris Journal: J Prim Prev Date: 2009-08-19
Authors: Helen C Kales; Donald E Nease; Jo Anne Sirey; Kara Zivin; Hyungjin Myra Kim; Janet Kavanagh; Shana Lynn; Claire Chiang; Harold W Neighbors; Marcia Valenstein; Frederic C Blow Journal: Am J Geriatr Psychiatry Date: 2013-02-06 Impact factor: 4.105